Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Pashayan

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Nature Reviews. Clinical Oncology|March 11, 2020
Peridiagnostic and cascade cancer genetic testingNora Pashayan, Clare Turnbull
BMJ Quality & Safety|November 10, 2019
When evidence says no: gynaecologists' reasons for (not) recommending ineffective ovarian cancer screeningOdette Wegwarth, Nora Pashayan
Personalized Medicine|September 18, 2012
Population-based screening in the era of genomicsNora Pashayan, Paul Pharoah
Human Genetics|April 13, 2011
Translating genomics into improved population screening: hype or hope?Nora Pashayan, Paul Pharoah
Journal of Research in Nursing : JRN|March 7, 2022
Implementing a novel programme for nurses and allied health professionals to develop capacity for evidence-informed clinical practiceSilvie Cooper, Julie Sanders, Nora Pashayan
Genetic Epidemiology|November 28, 2017
Predictive accuracy of combined genetic and environmental risk scoresFrank Dudbridge, Nora Pashayan, Jian Yang
Science (New York, N.Y.)|May 9, 2020
The challenge of early detection in cancerNora Pashayan, Paul D P Pharoah
JAMA Oncology|January 20, 2022
Concerns About Methods Used in Modeling Study of Risk-Stratified Screening for Breast CancerNora Pashayan, Paul D P Pharoah
BMC Health Services Research|June 27, 2006
Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertilityNora Pashayan, Georgios Lyratzopoulos, Raj Mathur
JAMA Oncology|January 18, 2019
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-ReplyNora Pashayan, Paul D P Pharoah
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Nature Reviews. Clinical Oncology|March 11, 2020
Peridiagnostic and cascade cancer genetic testingNora Pashayan, Clare Turnbull
BMJ Quality & Safety|November 10, 2019
When evidence says no: gynaecologists' reasons for (not) recommending ineffective ovarian cancer screeningOdette Wegwarth, Nora Pashayan
Personalized Medicine|September 18, 2012
Population-based screening in the era of genomicsNora Pashayan, Paul Pharoah
Human Genetics|April 13, 2011
Translating genomics into improved population screening: hype or hope?Nora Pashayan, Paul Pharoah
Journal of Research in Nursing : JRN|March 7, 2022
Implementing a novel programme for nurses and allied health professionals to develop capacity for evidence-informed clinical practiceSilvie Cooper, Julie Sanders, Nora Pashayan
Genetic Epidemiology|November 28, 2017
Predictive accuracy of combined genetic and environmental risk scoresFrank Dudbridge, Nora Pashayan, Jian Yang
Science (New York, N.Y.)|May 9, 2020
The challenge of early detection in cancerNora Pashayan, Paul D P Pharoah
JAMA Oncology|January 20, 2022
Concerns About Methods Used in Modeling Study of Risk-Stratified Screening for Breast CancerNora Pashayan, Paul D P Pharoah
BMC Health Services Research|June 27, 2006
Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertilityNora Pashayan, Georgios Lyratzopoulos, Raj Mathur
JAMA Oncology|January 18, 2019
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-ReplyNora Pashayan, Paul D P Pharoah
Pageof 18